Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
收藏DataCite Commons2025-12-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012048/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This trial is conducted in the United States of America (USA). The purpose of the trial is to investigate the effect and safety of liraglutide 3.0 mg as an adjunct to intensive behaviour therapy for obesity in a non-specialist setting (IBT-CMS: Intensive Behaviour Therapy for obesity in a primary care setting according to Centers for Medicare \& Medicaid Services (CMS) visit schedule).
提供机构：
Vivli
创建时间：
2025-12-05
